AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Drax Group PLC

Transaction in Own Shares Aug 28, 2018

4844_rns_2018-08-28_d63f0873-c4f4-4870-bb44-ff9ddad55fad.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0476Z

Drax Group PLC

28 August 2018

Transactions in own shares

Drax Group plc (the Company) announces today it has purchased the following number of its ordinary shares of 11 16/29 pence each through J.P. Morgan Securities plc.

Date of purchase: 28 August 2018
Aggregate number of ordinary shares purchased: 67,781
Lowest price paid per share: 382.60000
Highest price paid per share: 387.00000
Average price paid per share: 385.25004

The Company intends to hold the purchased shares in treasury.

Since 20 April 2018, the Company has purchased 6,935,575 shares at a cost (including dealing and associated costs) of £23,732,466.35.

Following the above transaction, the Company holds 6,935,575, of its ordinary shares in treasury and has 400,174,958 ordinary shares in issue (excluding treasury shares).

The table below contains detailed information about the purchases made as part of the buyback programme.

Schedule of Purchases

Shares purchased: 67,781 (ISIN: GB00B1VNSX38)
Date of purchases: 28 August 2018
Investment firm: J.P. Morgan Securities plc

Aggregate information:

Venue Volume-weighted average price (GBp) Aggregated volume Lowest price per share (GBp) Highest price per share (GBp)
London Stock Exchange 385.25004 67,781 382.60000 387.00000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSEASPPALAPEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.